GT BIOPHARMA INC

CUSIP: 36254L209 Class: COMMON

Silverleafe Capital Partners, LLC's Holding History (CIK: 0001535611)

Note: Option positions (PUT/CALL) are excluded.

Q3 2021
Shares 105,000 Value ($000) $708 Avg Close — Range —
Q2 2021
Shares 104,000 Value ($000) $1,612 Avg Close — Range —